Tinoridine-hydrochloride-Y-3642-hydrochloride-DataSheet-MedChemExpress_第1頁(yè)
Tinoridine-hydrochloride-Y-3642-hydrochloride-DataSheet-MedChemExpress_第2頁(yè)
Tinoridine-hydrochloride-Y-3642-hydrochloride-DataSheet-MedChemExpress_第3頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemETinoridine hydrochlorideCat. No.: HY-111354CAS No.: 25913-34-2Synonyms: Y-3642 hydrochloride分式: CHClNOS分量: 352.88作靶點(diǎn): Glutathione Peroxidase作通路: Metabolic Enzyme/Protease儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months

2、-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 31 mg/mL (87.85 mM)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 2.8338 mL 14.1691 mL 28.3382 mL5 mM 0.5668 mL 2.8338 mL 5.6676 mL10 mM 0.2834 mL 1.4169 mL 2.8338 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲(chǔ)備液,并請(qǐng)注意儲(chǔ)備液的保存式和期限。BIOLOGICAL ACTIVI

3、TY物活性 Tinoridine hydrochloride種甾體抗炎藥,也具有強(qiáng)效的由基清除和抗過(guò)氧化物活性。體外研究Tinoridine reduces a stable free radical, diphenyl-p-picrylhydrazyl, in the molar ratio of about 1:2, indicatingits free radical scavenging ability. Tinoridine inhibits the lipid peroxidation in rat liver microsomes induced byxanthine-xanth

4、ine oxidase system in the presence of ADP and Fe2+, in which hydroxyl radical is formed.1/2 Master of Small Molecules 您邊的抑制劑師www.MedChemETinoridine is demonstrated to be oxidized in the course of the lipid peroxidation by following the fluorescencederived from the oxidation product of tinoridine. It

5、 is also oxidized by the xanthine-xanthine oxidase system inthe presence of Fe2+, but its oxidation is slow in the absence of Fe2+ and almost completely inhibited bycatalase. Tinoridine is also oxidized by H2O2-Fe2+ system producing OH (Fenton reaction), but it does notaffect the reduction of cytoch

6、rome c caused by superoxide radical 1.體內(nèi)研究 CCl4 aministration produces a marked decrease in the concentrations of liver microsomal cytochrome P-450and G6Pase, indicating that hepatic endoplasmic reticulum function is disrupted. Prior treatment of theanimals with tinoridine (100 mg/kg) significantly

7、reduces the CCl4-induced alterations in the enzymeactivities, and a rapid recovery toward the normal values is observed 2.PROTOCOLKinase Assay 2 CCl4 aministration produces a marked decrease in the concentrations of liver microsomal cytochrome P-450and G6Pase, indicating that hepatic endoplasmic ret

8、iculum function is disrupted. Prior treatment of theanimals with tinoridine (100 mg/kg) significantly reduces the CCl4-induced alterations in the enzymeactivities, and a rapid recovery toward the normal values is observed 2.MCE has not independently confirmed the accuracy of these methods. They are

9、for reference only.Animal Rat: Male Wistar rats (180-220 g) are used in the experiments. Drugs (Tinoridine) are given orally as aAdministration 2 suspension in 0.5% methylcellulose solution 1 hr before CCl4, administration. Control animals receive anequivalent amount of the vehicle. CCl4 is administ

10、ered ip at a dose of 0.25 ml/kg as a 5% (v/v) solution inolive oil. The animals are killed by carotid excision at different times after CCl4 administration; the livers arerapidly removed, weighed and processed for biochemical or histologic analysis 2.MCE has not independently confirmed the accuracy

11、of these methods. They are for reference only.REFERENCES1. O Shimada, et al. Hydroxyl radical scavenging action of tinoridine. Agents Actions. 1986 Nov;19(3-4):208-14.2. Yasuda H, et al. The protective effect of tinoridine against carbon tetrachloride hepatotoxicity. Toxicol Appl Pharmacol. 1980 Mar15;52(3):407-13.McePdfHeightCaution: Product has not

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論